|A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer|
A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ...
Cancer discovery 1 (6), 508-523, 2011
|Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast …|
P Cassoni, M Papotti, C Ghè, F Catapano, A Sapino, A Graziani, ...
The Journal of Clinical Endocrinology & Metabolism 86 (4), 1738-1745, 2001
|Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance|
E Devarajan, AA Sahin, JS Chen, RR Krishnamurthy, N Aggarwal, ...
Oncogene 21 (57), 8843-8851, 2002
|The 2019 WHO classification of tumours of the breast|
PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ...
|Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer|
G Cserni, D Gregori, F Merletti, A Sapino, MP Mano, A Ponti, S Sandrucci, ...
Journal of British Surgery 91 (10), 1245-1252, 2004
|Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines|
G Cserni, I Amendoeira, N Apostolikas, JP Bellocq, S Bianchi, G Bussolati, ...
European Journal of Cancer 39 (12), 1654-1667, 2003
|Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers|
I Castellano, E Allia, V Accortanzo, AM Vandone, L Chiusa, R Arisio, ...
Breast cancer research and treatment 124, 607-617, 2010
|Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up|
S Bustreo, S Osella-Abate, P Cassoni, M Donadio, M Airoldi, F Pedani, ...
Breast cancer research and treatment 157, 363-371, 2016
|SF3B1 mutations constitute a novel therapeutic target in breast cancer|
SL Maguire, A Leonidou, P Wai, C Marchiò, CKY Ng, A Sapino, ...
The Journal of pathology 235 (4), 571-580, 2015
|Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis|
C Marchio, MB Lambros, P Gugliotta, LV Di Cantogno, C Botta, B Pasini, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
|Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for …|
G Cserni, I Amendoeira, N Apostolikas, JP Bellocq, S Bianchi, W Boecker, ...
Journal of clinical pathology 57 (7), 695-701, 2004
|Expression of the neuroendocrine phenotype in carcinomas of the breast.|
A Sapino, L Righi, P Cassoni, M Papotti, F Pietribiasi, G Bussolati
Seminars in diagnostic pathology 17 (2), 127-137, 2000
|Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management|
A Sapino, P Cassoni, E Zanon, F Fraire, S Croce, C Coluccia, M Donadio, ...
British journal of cancer 88 (5), 702-706, 2003
|HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary …|
S Doublier, DC Belisario, M Polimeni, L Annaratone, C Riganti, E Allia, ...
BMC cancer 12 (1), 1-15, 2012
|Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond|
C Marchiò, L Annaratone, A Marques, L Casorzo, E Berrino, A Sapino
Seminars in cancer biology 72, 123-135, 2021
|Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women|
A Sapino, L Righi, P Cassoni, M Papotti, P Gugliotta, G Bussolati
Modern Pathology 14 (8), 768-776, 2001
|Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast|
C Marchio, M Iravani, R Natrajan, MB Lambros, K Savage, N Tamber, ...
The Journal of pathology 215 (4), 398-410, 2008
|p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene–dependent breast tumorigenesis|
S Cabodi, A Tinnirello, P Di Stefano, B Bisarò, E Ambrosino, I Castellano, ...
Cancer research 66 (9), 4672-4680, 2006
|Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody.|
P Gugliotta, A Sapino, L Macrí, O Skalli, G Gabbiani, G Bussolati
Journal of Histochemistry & Cytochemistry 36 (6), 659-663, 1988
|Endothelial cell differentiation of human breast tumour stem/progenitor cells|
B Bussolati, C Grange, A Sapino, G Camussi
Journal of cellular and molecular medicine 13 (2), 309-319, 2009